Because what I am starting to see is that these different metabolic types seem to dictate our reactions to how you are going to give progesterone or estrogen
Understanding these differences is crucial as we move toward #precisionmedicine matching the right drug to the right patient based on biology, and in the case of obesity, not just BMI
For example, a randomized, double-blind, placebo-controlled trial in patients with overweight or obesity -associated KOA assessed the effects of liraglutide (3 mg/day) over 52 weeks as an add-on to dietary guidance [47, 48]
While losing weight can feel like a big win, the changes in facial fullness can sometimes make you look older or more tired than you actually are
D-2-hydroxyglutaric aciduria: a case with an intermediate phenotype and prenatal diagnosis of two affected fetuses
Pain 161 , 20792088 (2020)